APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urinary Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Urinary Drugs Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchUrinary Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Urinary Drugs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Urinary Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urinary Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Urinary Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Urinary Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Urinary Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Urinary Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Urinary Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Urinary Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Urinary Drugs include Sanofi S.A., Pfizer Inc., GlaxosmithKline Plc., Bayer AG, Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Company Limited, Astellas Pharma Inc. and Allergan Plc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Urinary Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Urinary Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Urinary Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Urinary Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Urinary Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Urinary Drugs sales, projected growth trends, production technology, application and end-user industry.

Urinary Drugs Segment by Company

Sanofi S.A.

Pfizer Inc.

GlaxosmithKline Plc.

Bayer AG

Otsuka Pharmaceutical Co., Ltd.

Daiichi Sankyo Company Limited

Astellas Pharma Inc.

Allergan Plc.

Urinary Drugs Segment by Type

Oral

Injectables

Urinary Drugs Segment by Application

Clinic

Hospital

Home Care

Urinary Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urinary Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urinary Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Urinary Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Urinary Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urinary Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Urinary Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injectables Major Manufacturers Table 4. Global Urinary Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Home Care Major Manufacturers Table 8. Urinary Drugs Industry Trends Table 9. Urinary Drugs Industry Drivers Table 10. Urinary Drugs Industry Opportunities and Challenges Table 11. Urinary Drugs Industry Restraints Table 12. Global Urinary Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Urinary Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Urinary Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Urinary Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Urinary Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Urinary Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 18. Global Urinary Drugs Sales by Region (2021-2026) & (k tons) Table 19. Global Urinary Drugs Sales by Region (2027-2032) & (k tons) Table 20. Global Urinary Drugs Sales Market Share by Region (2021-2026) Table 21. Global Urinary Drugs Sales Market Share by Region (2027-2032) Table 22. Global Urinary Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Urinary Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Urinary Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Urinary Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Urinary Drugs Sales Price (US$/ton) of Manufacturers (2021-2026) Table 27. Global Urinary Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Urinary Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Urinary Drugs Manufacturers, Product Type & Application Table 30. Global Urinary Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Urinary Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Urinary Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Urinary Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Urinary Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Urinary Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Urinary Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Urinary Drugs Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 39. Global Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 40. Global Urinary Drugs Sales by Type (2027-2032) & (k tons) Table 41. Global Urinary Drugs Sales Market Share by Type (2021-2026) Table 42. Global Urinary Drugs Sales Market Share by Type (2027-2032) Table 43. Global Urinary Drugs Price by Type (2021-2026) & (US$/ton) Table 44. Global Urinary Drugs Price by Type (2027-2032) & (US$/ton) Table 45. Global Urinary Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Urinary Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Urinary Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Urinary Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Urinary Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Urinary Drugs Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 51. Global Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 52. Global Urinary Drugs Sales by Application (2027-2032) & (k tons) Table 53. Global Urinary Drugs Sales Market Share by Application (2021-2026) Table 54. Global Urinary Drugs Sales Market Share by Application (2027-2032) Table 55. Global Urinary Drugs Price by Application (2021-2026) & (US$/ton) Table 56. Global Urinary Drugs Price by Application (2027-2032) & (US$/ton) Table 57. Sanofi S.A. Company Information Table 58. Sanofi S.A. Business Overview Table 59. Sanofi S.A. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 60. Sanofi S.A. Urinary Drugs Product Portfolio Table 61. Sanofi S.A. Recent Development Table 62. Pfizer Inc. Company Information Table 63. Pfizer Inc. Business Overview Table 64. Pfizer Inc. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 65. Pfizer Inc. Urinary Drugs Product Portfolio Table 66. Pfizer Inc. Recent Development Table 67. GlaxosmithKline Plc. Company Information Table 68. GlaxosmithKline Plc. Business Overview Table 69. GlaxosmithKline Plc. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. GlaxosmithKline Plc. Urinary Drugs Product Portfolio Table 71. GlaxosmithKline Plc. Recent Development Table 72. Bayer AG Company Information Table 73. Bayer AG Business Overview Table 74. Bayer AG Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Bayer AG Urinary Drugs Product Portfolio Table 76. Bayer AG Recent Development Table 77. Otsuka Pharmaceutical Co., Ltd. Company Information Table 78. Otsuka Pharmaceutical Co., Ltd. Business Overview Table 79. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Product Portfolio Table 81. Otsuka Pharmaceutical Co., Ltd. Recent Development Table 82. Daiichi Sankyo Company Limited Company Information Table 83. Daiichi Sankyo Company Limited Business Overview Table 84. Daiichi Sankyo Company Limited Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Daiichi Sankyo Company Limited Urinary Drugs Product Portfolio Table 86. Daiichi Sankyo Company Limited Recent Development Table 87. Astellas Pharma Inc. Company Information Table 88. Astellas Pharma Inc. Business Overview Table 89. Astellas Pharma Inc. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Astellas Pharma Inc. Urinary Drugs Product Portfolio Table 91. Astellas Pharma Inc. Recent Development Table 92. Allergan Plc. Company Information Table 93. Allergan Plc. Business Overview Table 94. Allergan Plc. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Allergan Plc. Urinary Drugs Product Portfolio Table 96. Allergan Plc. Recent Development Table 97. North America Urinary Drugs Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Urinary Drugs Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 100. North America Urinary Drugs Sales by Type (2027-2032) & (k tons) Table 101. North America Urinary Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 102. North America Urinary Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 103. North America Urinary Drugs Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Urinary Drugs Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 106. North America Urinary Drugs Sales by Application (2027-2032) & (k tons) Table 107. North America Urinary Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 108. North America Urinary Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 109. North America Urinary Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Urinary Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Urinary Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Urinary Drugs Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 113. North America Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 114. North America Urinary Drugs Sales by Country (2027-2032) & (k tons) Table 115. North America Urinary Drugs Sales Price by Country (2021-2026) & (US$/ton) Table 116. North America Urinary Drugs Sales Price by Country (2027-2032) & (US$/ton) Table 117. United States Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 118. Canada Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 119. Mexico Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 120. Europe Urinary Drugs Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Urinary Drugs Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 123. Europe Urinary Drugs Sales by Type (2027-2032) & (k tons) Table 124. Europe Urinary Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 125. Europe Urinary Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 126. Europe Urinary Drugs Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Urinary Drugs Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 129. Europe Urinary Drugs Sales by Application (2027-2032) & (k tons) Table 130. Europe Urinary Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 131. Europe Urinary Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 132. Europe Urinary Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Urinary Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Urinary Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Urinary Drugs Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 136. Europe Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 137. Europe Urinary Drugs Sales by Country (2027-2032) & (k tons) Table 138. Europe Urinary Drugs Sales Price by Country (2021-2026) & (US$/ton) Table 139. Europe Urinary Drugs Sales Price by Country (2027-2032) & (US$/ton) Table 140. Germany Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 141. France Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 142. U.K. Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 143. Italy Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 144. Russia Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 145. Spain Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 147. Switzerland Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 148. Sweden Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 149. Poland Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 150. China Urinary Drugs Revenue by Type (2021-2026) & (US$ Million) Table 151. China Urinary Drugs Revenue by Type (2027-2032) & (US$ Million) Table 152. China Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 153. China Urinary Drugs Sales by Type (2027-2032) & (k tons) Table 154. China Urinary Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 155. China Urinary Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 156. China Urinary Drugs Revenue by Application (2021-2026) & (US$ Million) Table 157. China Urinary Drugs Revenue by Application (2027-2032) & (US$ Million) Table 158. China Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 159. China Urinary Drugs Sales by Application (2027-2032) & (k tons) Table 160. China Urinary Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 161. China Urinary Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 162. Asia Urinary Drugs Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Urinary Drugs Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 165. Asia Urinary Drugs Sales by Type (2027-2032) & (k tons) Table 166. Asia Urinary Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 167. Asia Urinary Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 168. Asia Urinary Drugs Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Urinary Drugs Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 171. Asia Urinary Drugs Sales by Application (2027-2032) & (k tons) Table 172. Asia Urinary Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 173. Asia Urinary Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 174. Asia Urinary Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Urinary Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Urinary Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Urinary Drugs Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 178. Asia Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 179. Asia Urinary Drugs Sales by Country (2027-2032) & (k tons) Table 180. Asia Urinary Drugs Sales Price by Country (2021-2026) & (US$/ton) Table 181. Asia Urinary Drugs Sales Price by Country (2027-2032) & (US$/ton) Table 182. Japan Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 183. South Korea Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 184. India Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 185. Australia Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 186. Taiwan Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Urinary Drugs Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Urinary Drugs Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 191. SAMEA Urinary Drugs Sales by Type (2027-2032) & (k tons) Table 192. SAMEA Urinary Drugs Sales Price by Type (2021-2026) & (US$/ton) Table 193. SAMEA Urinary Drugs Sales Price by Type (2027-2032) & (US$/ton) Table 194. SAMEA Urinary Drugs Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Urinary Drugs Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 197. SAMEA Urinary Drugs Sales by Application (2027-2032) & (k tons) Table 198. SAMEA Urinary Drugs Sales Price by Application (2021-2026) & (US$/ton) Table 199. SAMEA Urinary Drugs Sales Price by Application (2027-2032) & (US$/ton) Table 200. SAMEA Urinary Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Urinary Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Urinary Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Urinary Drugs Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 204. SAMEA Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 205. SAMEA Urinary Drugs Sales by Country (2027-2032) & (k tons) Table 206. SAMEA Urinary Drugs Sales Price by Country (2021-2026) & (US$/ton) Table 207. SAMEA Urinary Drugs Sales Price by Country (2027-2032) & (US$/ton) Table 208. Brazil Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 209. Argentina Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 210. Chile Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 211. Colombia Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 212. Peru Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 214. Israel Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 215. UAE Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 216. Turkey Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 217. Iran Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 218. Egypt Urinary Drugs Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Urinary Drugs Distributors List Table 222. Urinary Drugs Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Urinary Drugs Image Figure 2. Global Urinary Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urinary Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injectables Image Figure 6. Global Urinary Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Urinary Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Home Care Image Figure 11. Global Urinary Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Urinary Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Urinary Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Urinary Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Urinary Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Urinary Drugs Sales (2021-2032) & (k tons) Figure 17. Global Urinary Drugs Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 18. Global Urinary Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Urinary Drugs Sales YoY (2021-2032) & (k tons) Figure 20. Europe Urinary Drugs Sales YoY (2021-2032) & (k tons) Figure 21. China Urinary Drugs Sales YoY (2021-2032) & (k tons) Figure 22. Asia (Excluding China) Urinary Drugs Sales YoY (2021-2032) & (k tons) Figure 23. South America, Middle East and Africa Urinary Drugs Sales YoY (2021-2032) & (k tons) Figure 24. Global Urinary Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Urinary Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Urinary Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Urinary Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Urinary Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Urinary Drugs Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 31. Global Urinary Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Urinary Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Urinary Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Urinary Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Urinary Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Urinary Drugs Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 37. Global Urinary Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Urinary Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Urinary Drugs Revenue Share by Type (2021-2032) Figure 40. North America Urinary Drugs Sales Share by Type (2021-2032) Figure 41. North America Urinary Drugs Revenue Share by Application (2021-2032) Figure 42. North America Urinary Drugs Sales Share by Application (2021-2032) Figure 43. North America Urinary Drugs Revenue Share by Country (2021-2032) Figure 44. North America Urinary Drugs Sales Share by Country (2021-2032) Figure 45. Europe Urinary Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Urinary Drugs Sales Share by Type (2021-2032) Figure 47. Europe Urinary Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Urinary Drugs Sales Share by Application (2021-2032) Figure 49. Europe Urinary Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Urinary Drugs Sales Share by Country (2021-2032) Figure 51. China Urinary Drugs Revenue Share by Type (2021-2032) Figure 52. China Urinary Drugs Sales Share by Type (2021-2032) Figure 53. China Urinary Drugs Revenue Share by Application (2021-2032) Figure 54. China Urinary Drugs Sales Share by Application (2021-2032) Figure 55. Asia Urinary Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Urinary Drugs Sales Share by Type (2021-2032) Figure 57. Asia Urinary Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Urinary Drugs Sales Share by Application (2021-2032) Figure 59. Asia Urinary Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Urinary Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Urinary Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Urinary Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Urinary Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Urinary Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Urinary Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Urinary Drugs Sales Share by Country (2021-2032) Figure 67. Urinary Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Urinary Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injectables
Applications
  • Clinic
  • Hospital
  • Home Care
Companies covered
  • Sanofi S.A.
  • Pfizer Inc.
  • GlaxosmithKline Plc.
  • Bayer AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Daiichi Sankyo Company Limited
  • Astellas Pharma Inc.
  • Allergan Plc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Urinary Drugs Market by Type
  3. 1.2.1 Global Urinary Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injectables
  6. 1.3 Urinary Drugs Market by Application
  7. 1.3.1 Global Urinary Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Home Care
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Urinary Drugs Market Dynamics
  1. 2.1 Urinary Drugs Industry Trends
  2. 2.2 Urinary Drugs Industry Drivers
  3. 2.3 Urinary Drugs Industry Opportunities and Challenges
  4. 2.4 Urinary Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Urinary Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Urinary Drugs Revenue by Region
  3. 3.2.1 Global Urinary Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Urinary Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Urinary Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Urinary Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Urinary Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Urinary Drugs Sales by Region
  9. 3.4.1 Global Urinary Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Urinary Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Urinary Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Urinary Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Urinary Drugs Revenue by Manufacturers
  2. 4.1.1 Global Urinary Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Urinary Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Urinary Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Urinary Drugs Sales by Manufacturers
  6. 4.2.1 Global Urinary Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Urinary Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Urinary Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Urinary Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Urinary Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Urinary Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Urinary Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Urinary Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Urinary Drugs Market CR5 and HHI
  16. 4.8.2 2025 Urinary Drugs Tier 1, Tier 2, and Tier 3
5 Urinary Drugs Market by Type
  1. 5.1 Global Urinary Drugs Revenue by Type
  2. 5.1.1 Global Urinary Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Urinary Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Urinary Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Urinary Drugs Sales by Type
  6. 5.2.1 Global Urinary Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Urinary Drugs Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Urinary Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Urinary Drugs Price by Type
6 Urinary Drugs Market by Application
  1. 6.1 Global Urinary Drugs Revenue by Application
  2. 6.1.1 Global Urinary Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Urinary Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Urinary Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Urinary Drugs Sales by Application
  6. 6.2.1 Global Urinary Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Urinary Drugs Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Urinary Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Urinary Drugs Price by Application
7 Company Profiles
  1. 7.1 Sanofi S.A.
  2. 7.1.1 Sanofi S.A. Company Information
  3. 7.1.2 Sanofi S.A. Business Overview
  4. 7.1.3 Sanofi S.A. Urinary Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi S.A. Urinary Drugs Product Portfolio
  6. 7.1.5 Sanofi S.A. Recent Developments
  7. 7.2 Pfizer Inc.
  8. 7.2.1 Pfizer Inc. Company Information
  9. 7.2.2 Pfizer Inc. Business Overview
  10. 7.2.3 Pfizer Inc. Urinary Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc. Urinary Drugs Product Portfolio
  12. 7.2.5 Pfizer Inc. Recent Developments
  13. 7.3 GlaxosmithKline Plc.
  14. 7.3.1 GlaxosmithKline Plc. Company Information
  15. 7.3.2 GlaxosmithKline Plc. Business Overview
  16. 7.3.3 GlaxosmithKline Plc. Urinary Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxosmithKline Plc. Urinary Drugs Product Portfolio
  18. 7.3.5 GlaxosmithKline Plc. Recent Developments
  19. 7.4 Bayer AG
  20. 7.4.1 Bayer AG Company Information
  21. 7.4.2 Bayer AG Business Overview
  22. 7.4.3 Bayer AG Urinary Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer AG Urinary Drugs Product Portfolio
  24. 7.4.5 Bayer AG Recent Developments
  25. 7.5 Otsuka Pharmaceutical Co., Ltd.
  26. 7.5.1 Otsuka Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Product Portfolio
  30. 7.5.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Daiichi Sankyo Company Limited
  32. 7.6.1 Daiichi Sankyo Company Limited Company Information
  33. 7.6.2 Daiichi Sankyo Company Limited Business Overview
  34. 7.6.3 Daiichi Sankyo Company Limited Urinary Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Daiichi Sankyo Company Limited Urinary Drugs Product Portfolio
  36. 7.6.5 Daiichi Sankyo Company Limited Recent Developments
  37. 7.7 Astellas Pharma Inc.
  38. 7.7.1 Astellas Pharma Inc. Company Information
  39. 7.7.2 Astellas Pharma Inc. Business Overview
  40. 7.7.3 Astellas Pharma Inc. Urinary Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Astellas Pharma Inc. Urinary Drugs Product Portfolio
  42. 7.7.5 Astellas Pharma Inc. Recent Developments
  43. 7.8 Allergan Plc.
  44. 7.8.1 Allergan Plc. Company Information
  45. 7.8.2 Allergan Plc. Business Overview
  46. 7.8.3 Allergan Plc. Urinary Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Allergan Plc. Urinary Drugs Product Portfolio
  48. 7.8.5 Allergan Plc. Recent Developments
8 North America
  1. 8.1 North America Urinary Drugs Market Size by Type
  2. 8.1.1 North America Urinary Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Urinary Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Urinary Drugs Price by Type (2021-2032)
  5. 8.2 North America Urinary Drugs Market Size by Application
  6. 8.2.1 North America Urinary Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Urinary Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Urinary Drugs Price by Application (2021-2032)
  9. 8.3 North America Urinary Drugs Market Size by Country
  10. 8.3.1 North America Urinary Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Urinary Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Urinary Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Urinary Drugs Market Size by Type
  2. 9.1.1 Europe Urinary Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Urinary Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Urinary Drugs Price by Type (2021-2032)
  5. 9.2 Europe Urinary Drugs Market Size by Application
  6. 9.2.1 Europe Urinary Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Urinary Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Urinary Drugs Price by Application (2021-2032)
  9. 9.3 Europe Urinary Drugs Market Size by Country
  10. 9.3.1 Europe Urinary Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Urinary Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Urinary Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Urinary Drugs Market Size by Type
  2. 10.1.1 China Urinary Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Urinary Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Urinary Drugs Price by Type (2021-2032)
  5. 10.2 China Urinary Drugs Market Size by Application
  6. 10.2.1 China Urinary Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Urinary Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Urinary Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Urinary Drugs Market Size by Type
  2. 11.1.1 Asia Urinary Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Urinary Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Urinary Drugs Price by Type (2021-2032)
  5. 11.2 Asia Urinary Drugs Market Size by Application
  6. 11.2.1 Asia Urinary Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Urinary Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Urinary Drugs Price by Application (2021-2032)
  9. 11.3 Asia Urinary Drugs Market Size by Country
  10. 11.3.1 Asia Urinary Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Urinary Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Urinary Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Urinary Drugs Market Size by Type
  2. 12.1.1 SAMEA Urinary Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Urinary Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Urinary Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Urinary Drugs Market Size by Application
  6. 12.2.1 SAMEA Urinary Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Urinary Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Urinary Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Urinary Drugs Market Size by Country
  10. 12.3.1 SAMEA Urinary Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Urinary Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Urinary Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Urinary Drugs Value Chain Analysis
  2. 13.1.1 Urinary Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Urinary Drugs Production Mode & Process
  6. 13.2 Urinary Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Urinary Drugs Distributors
  9. 13.2.3 Urinary Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst